IP Library Granted Patent US 12,576,287
Granted Patent B2
US 12,576,287 · App. 18/286,330 · Granted Mar 17, 2026

Circular accelerator and particle beam treatment system

Inventors: Futaro Ebina (Tokyo, JP); Kenji Miyata (Tokyo, JP)
Assignee: HITACHI HIGH-TECH CORPORATION
A61N5/1081H05H13/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,576,287
App. No.
18/286,330
Granted
Mar 17, 2026
Kind
B2
Abstract

There is provide a circular accelerator and a particle beam therapy system that can improve the beam extraction efficiency. A circular accelerator that accelerates and extracts charged particle beams circulating in a magnetic field includes a first magnetic field region in which closed trajectories of the beams with different energies are eccentric and which has a magnetic field gradient decreasing in the magnetic field toward an outer peripheral side and a second magnetic field region having a magnetic field gradient increasing in the magnetic field toward the outer peripheral side. A border between the first magnetic field region and the second magnetic field region is located on a downstream side in a traveling direction of the beam with respect to a predetermined region in which an interval between the closed trajectories of the beams with the different energies is narrowest.

Claims (8)

1 . A circular accelerator that accelerates and extracts charged particle beams circulating in a magnetic field, the circular accelerator comprising:

a first magnetic field region in which closed trajectories of the beams with different energies are eccentric and which has a magnetic field gradient decreasing in the magnetic field toward an outer peripheral side; and

a second magnetic field region having a magnetic field gradient increasing in the magnetic field toward an outer peripheral side,

wherein a border between the first magnetic field region and the second magnetic field region is located on a downstream side in a traveling direction of the beam with respect to a predetermined region in which an interval between the closed trajectories of the beams with the different energies is narrowest.

2 . The circular accelerator according to claim 1 , wherein the border between the first magnetic field region and the second magnetic field region is located on a downstream side in the traveling direction of the beam with respect to a predetermined region in which an interval between closed trajectories of the beams with different energies is narrowest, and a center of the first magnetic field region in the beam traveling direction is located on an upstream side in the beam traveling direction with respect to the predetermined region.

3 . The circular accelerator according to claim 1 , wherein the border between the first magnetic field region and the second magnetic field region exists in a range from a point located downstream of the predetermined region in the traveling direction of the beam to a point less than 90°.

4 . The circular accelerator according to claim 1 , wherein a distance from a central orbit of the beam to the second magnetic field region is larger than a distance from the central orbit of the beam to the first magnetic field region.

5 . A particle beam therapy system using the circular accelerator according to claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2024
From: HITACHI, LTD.
To: HITACHI HIGH-TECH CORPORATION
Reel/Frame 068078/0381 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2023
From: EBINA, FUTARO; MIYATA, KENJI
To: HITACHI, LTD.
Reel/Frame 065173/0491 →
Priority Claims (1)
JP 2021-127695 · Aug 3, 2021 · national
Continuity (1)
Related Publication 20240198138A1 · Jun 20, 2024
References Cited (15)
US 10548212B2 · Aoki · 2020 [cited by examiner]
US 20190239333A1 · Aoki · 2019 [cited by applicant]
US 20210195725A1 · Hae · 2021 [cited by examiner]
US 20210196984A1 · Hae · 2021 [cited by examiner]
US 20230105721A1 · Hae et al. · 2023 [cited by applicant]
US 20240244737A1 · Hori et al. · 2024 [cited by applicant]
CN 111279801A · 2020 [cited by applicant]
CN 117356173A · 2024 [cited by applicant]
EP 4358653A1 · 2024 [cited by applicant]
JP 2019133745A · 2019 [cited by applicant]
JP 2020038797A · 2020 [cited by applicant]
JP 6714146B2 · 2020 [cited by applicant]
JP 2021007645A · 2021 [cited by applicant]
Extended European Search Report received in corresponding European Application No. 22852882.4 dated May 15, 2025. [cited by applicant]
Chinese Office Action received in corresponding Chinese Application No. 202280019016.X dated Jan. 29, 2026. [cited by applicant]